马萨诸塞州过量剂量教育和纳洛分发计划 (MA OEND) 中纳洛分发模式的地理空间分析
Timothy W Levengood1, Leah C Shaw2, Xiao Zang3
1Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA; Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL, USA.
Drug and alcohol dependence
|July 19, 2025
概括
纳洛 (Narcan) 救援套件经常被用于其分发区域以外的地区,这凸显了对抗阿片类药物危机的灵活策略的需要. 这项研究分析了分布和使用模式,以确定区域的余和短缺.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 药物滥用研究 药物滥用研究
背景情况:
- 阿片类药物过量危机需要有效的纳洛 (Narcan) 分布策略.
- 了解纳洛的分发和管理模式对于优化其可访问性和影响至关重要.
- 地理分析是确定纳洛过剩或缺乏地区的关键.
研究的目的:
- 评估纳洛套件是否在发放的同一个社区使用.
- 探索最佳的地理边界来比较纳洛的供应和需求.
- 通过分析流动模式,识别纳洛过剩或不足的区域.
主要方法:
- 利用了马萨诸塞州过量剂量教育和纳洛分发 (OEND) 计划 (2018-2020) 的数据.
- 在邮政编码层面上连接参与者的居住地,过量救援企图和充电地点.
- 开发了"纳洛服务区" (NSA) 和计算了纳洛配方套件与过量服用死亡的比率.
主要成果:
- 在49,344个人中,发生了88,085次纳洛开放接触.
- 16%的纳洛遭遇涉及先前报告的救援尝试.
- 在居住和救援地点之间观察到大量的迁移,波士顿的分布很大.
- 纳洛分发过量死亡的平均比率为每例死亡14套,在NSA中从8套到32套不等.
结论:
- 纳洛套件经常被居住在不同社区的个人使用,而不是套件被发放的地方.
- 纳洛覆盖率的显著区域差异表明供需差异.
- 这些发现强调了考虑纳洛的流动性对于有效的公共卫生干预的重要性.
相关概念视频
Analysis of Population Pharmacokinetic Data
389
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
389
Drug Distribution: Volume of Distribution
6.0K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
6.0K
Drug Distribution: Overview
303
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
303
Manipulation and Analysis
61
GIS manipulation and analysis functions are vital for decision-making and planning. These activities range from data retrieval tasks, such as selecting information based on specific criteria, to advanced analytical techniques that address complex spatial problems.One critical GIS analysis method is overlaying, which combines multiple data layers to examine impacts. For example, overlaying a river-dammed lake boundary with road networks can identify affected infrastructure. Another common...
61
Drug Distribution: Tissue Binding
3.2K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.2K
Opioid Receptors: Overview
1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K


